DiaCarta

DiaCarta Radiation Toxicity Liquid Biopsy Test Deployed in Florida Cancer Treatment Response Project

DiaCarta's RadTox cell-free DNA test will be used throughout Florida as part of a $1 million research project financed by the Florida Cancer Innovation Fund.

DiaCarta, OncoAssure Collaborate on Prostate Cancer LDT Launch

The firms said that DiaCarta's laboratory facilities in California will be used to validate the prostate cancer assay for a commercial launch.

DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration

Working under a two-year cooperative R&D agreement, the firm will explore its platform for cancer and rare disease mutation detection and in situ cancer cell analyses.

DiaCarta

DiaCarta Radiation Toxicity Liquid Biopsy Test Deployed in Florida Cancer Treatment Response Project

DiaCarta, OncoAssure Collaborate on Prostate Cancer LDT Launch

DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration

EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage

BlackfinBio Launching Gene Therapy Trial in Rare Neurological Condition at Boston Children's

Clasp Therapeutics Initiates Phase I Trial of T-Cell Engager

AccuStem Sciences Partners With EmeritusDx on Molecular Lung Cancer Screening Test

Craif Raises $22M in Series C Round to Expand US, Japan Operations

CHMP Issues Positive Recommendation for Jazz Pharmaceuticals' Ziihera